BEIJING, Dec. 18, 2025 /PRNewswire/ -- Syneron Bio, an macrocyclic peptide drug discovery company driven by intelligent high-throughput platform, has successfully completed its Series A and A+ financing rounds, raising close to USD 100 million in total. Top-tier investors participated in...
Hence then, the article about syneron bio closes nearly 100m in series a and a rounds was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Syneron Bio Closes Nearly $100M in Series A and A+ Rounds )
Also on site :
- Travel Warning Issued For Millions Across US
- ‘Change is inevitable’: What is next for Iran?
- Australian Open: Sinner overcomes cramps; Keys, Pegula advance; Osaka withdraws